|
| |
| | | 68684 | | 24.02.2023 | | Novartis Pharma Schweiz AG | | | | | | | 23.02.2028 | | | | | | | | | | 17.02. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Pluvicto 1000 MBq/ml | Injektions-/Infusionslösung | Infusion solution (Lutetium(177lu) Vipivotidum Tetraxetanum 1000 MBq/ml) | V10XX05 | |
|
|
|
